Frequency of monocyte subsets is linked to the severity of atherosclerosis in patients with ischemic heart disease: a case-control study

Abstract

Background: Monocytes are recognized as central cells in the progression of atherosclerosis, and are subcategorized into classical (CD14++CD16 lo), intermediate (CD14++CD16 hi) and non-classical (CD14+CD16 hi) subsets. Purpose: The present study aimed to assess the relationships between different subsets of monocytes, metabolic and inflammatory factors in patients with stable coronary heart disease. Methods: A total of 26 patients (both men and women) with stable ischemic heart disease (IHD) were recruited. Among all the recruited patients, 17 patients had significant coronary artery disease defined as diameter stenosis more than 70%. Severity of CHD was assessed by the Gensini score (GS). Counts of CD14++CD16 lo , CD14++CD16 hi , and CD14+CD16 hi monocytes were evaluated by flow cytometry. Gating was verified and expression of CD163 was determined by imaging flow cytometry. Key cardiac markers, cytokines, and chemokines were detected in serum and in 24-hour-culture medium for peripheral blood mononuclear cells (PBMC) by multiplex analysis. The Mann-Whitney U-test and Spearman's rank correlation coefficient (r) were used for statistical analysis. Results: Patients with stenosis <70% tended to have higher frequency of CD14+CD16 hi monocytes compared to patients with coronary artery stenosis >70%. The frequencies of CD163+CD14++CD16 hi and CD163+CD14+CD16 hi monocytes were elevated in patients with stenosis >70%. In patients with stenosis <70%, the frequency of classical monocytes positively correlated and the frequency of non-classical monocytes negatively correlated with the value of GS (R ¼ 0.757; p ¼ 0.018 and R ¼-0.757; p ¼ 0.018, respectively). Conclusions: In patients with ischemic heart disease, the frequency of classical monocytes was directly correlated with the severity of atherosclerosis, while the frequency of non-classical monocytes was correlated inversely. The effects of these monocyte subsets in the development of myocardial ischemia still need to be elucidated.

Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction

“…Mainly they represent a patrolling monocyte population, being found close to the vessel wall in the circulation and scavenging oxidized lipids, cellular debris and pathogens ( 58 ). According to our data the frequency of non-classical monocytes inversely correlates with the severity of atherosclerosis in patients with stable coronary artery disease ( 63 ). One may speculate that it is non-classical monocytes that are essential for the resolution of inflammation in AMI, as late recruitment of monocytes in the models of acute inflammation did not depend on the CCR2 expression ( 64 ).…”

Non‐classical monocytes frequency and serum vitamin D3 levels are linked to diabetic foot ulcer associated with peripheral artery disease

“…It was reported that HDL blocks monocyte activation, proliferation and differentiation, which reduces the inflammatory response that monocytes induce 43 . Kologrivova et al 47 . observed a direct correlation between TG/HDL and circulating CD16 + monocytes.…”

Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia

“…The frequency of monocyte subsets has been linked to severity of atherosclerosis in patients with stable coronary heart disease (44). We measured two subsets of circulating monocytes, defined by surface expression levels of CD163 and CD14.…”